DR.REDDY'S LABORATORIESPharmaceuticalsINE089A01031Consolidated₹1185.00+10.00 (+0.85%)Jun-26
Valuation
Market Cap₹98.91K Cr
TTM PE30.63x
Forward PE39.48x
PEG-1.32
Book Value₹453.97
P/B2.61x
TTM EPS₹38.69
Fwd EPS₹30.01
TTM Revenue₹33.23K Cr
TTM PAT₹3.18K Cr
TTM EBITDA₹5.14K Cr
TTM EBIT₹3.02K Cr
Last Qtr PAT₹435.60 Cr
Last Qtr EBITDA₹859.90 Cr
Last Qtr EBIT₹323.30 Cr
Profitability
ROE8.40%
ROCE9.74%
TTM NPM9.58%
TTM EBITDA %15.47%
Curr OPM5.15%
Last OPM2.76%
Curr NPM—
Last NPM—
Curr EPS₹5.33
Last EPS₹2.65
Balance sheet
Equity₹83.50 Cr
Reserve₹37.81K Cr
Total Debt₹7,734.10 Cr
D/E0.20x
Interest %28.81%
Curr Interest₹125.50 Cr
Price / range
Close₹1185.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.85%
1W+1.67%
1M+0.53%
3M-6.51%
6M-8.44%
1Y-10.39%
2Y-9.79%
3Y+3.45%
5Y+21.30%
Diwali-5.47%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits